About 5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one
5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one (PubChem CID 157078504) has the molecular formula C70H59F3N30O4
and a molecular weight of 1441.44 g/mol. Its IUPAC name is 5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one.
Frequently Asked Questions
What is the IUPAC name of 5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one?
The IUPAC name of 5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one (CID 157078504) is 5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one.
What is the SMILES notation for 5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one?
The canonical SMILES for 5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one is CCc1cc(Nc2cnnc(-c3ccc4[nH][nH]c(=O)c4c3)n2)n[nH]1.Cc1cc(Nc2cnnc(-c3ccc4[nH][nH]c(=O)c4c3)c2)n[nH]1.O=c1[nH][nH]c2cc(C(F)(F)F)c(-c3cc(-c4ccncc4)nc(Nc4cc(C5CC5)[nH]n4)n3)cc12.O=c1[nH][nH]c2ccc(-c3cnnc(Nc4cc(C5CC5)[nH]n4)c3)cc12.
What is the InChIKey of 5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one?
The InChIKey is ADGIQLHTBYOPLQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H17F3N8O.C17H15N7O.C15H14N8O.C15H13N7O/c24-23(25,26)15-8-19-14(21(35)34-32-19)7-13(15)18-9-16(12-3-5-27-6-4-12)28-22(29-18)30-20-10-17(31-33-20)11-1-2-11;25-17-12-5-10(3-4-13(12)20-24-17)11-6-15(22-18-8-11)19-16-7-14(21-23-16)9-1-2-9;1-2-9-6-12(21-19-9)17-13-7-16-22-14(18-13)8-3-4-11-10(5-8)15(24)23-20-11;1-8-4-14(21-18-8)17-10-6-13(19-16-7-10)9-2-3-12-11(5-9)15(23)22-20-12/h3-11H,1-2H2,(H2,32,34,35)(H2,28,29,30,31,33);3-9H,1-2H2,(H2,20,24,25)(H2,19,21,22,23);3-7H,2H2,1H3,(H2,20,23,24)(H2,17,18,19,21,22);2-7H,1H3,(H2,20,22,23)(H2,17,18,19,21).
What are the key properties of 5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one?
5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one has a molecular weight of 1441.44 g/mol, XLogP of 11.22, 16 rotatable bonds, 16 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyridazin-4-yl]-1,2-dihydroindazol-3-one;5-[2-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-pyridin-4-ylpyrimidin-4-yl]-6-(trifluoromethyl)-1,2-dihydroindazol-3-one;5-[5-[(5-ethyl-1H-pyrazol-3-yl)amino]-1,2,4-triazin-3-yl]-1,2-dihydroindazol-3-one;5-[5-[(5-methyl-1H-pyrazol-3-yl)amino]pyridazin-3-yl]-1,2-dihydroindazol-3-one is sourced from PubChem (CID 157078504), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).